USC.edu
Are You a Patient?

Paibel I. Aguayo-Hiraldo

Assistant Professor of Clinical Pediatrics

Image of Paibel I. Aguayo-Hiraldo
Is this your profile? Click to edit
Email aguayohi@usc.edu
CTSI Profile

Publications

  • Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part IIOrgan Dysfunction and Immune Reconstitution Considerations for children with chronic GVHD after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2025 Jan 22. . View in PubMed
  • COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells Int J Cancer. 2024 Dec 15; 155(12):2190-2200. . View in PubMed
  • Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT Bone Marrow Transplant. 2024 Dec 03. . View in PubMed
  • Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group Transplant Cell Ther. 2024 Nov 26. . View in PubMed
  • Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White PatientsTransplant Cell Ther. 2024 Nov; 30(11):1061. e1-1061. e10. . View in PubMed
  • A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome Leuk Lymphoma. 2024 Sep; 65(9):1357-1361. . View in PubMed
  • Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD Blood. 2024 08 29; 144(9):1010-1021. . View in PubMed
  • Amphiregulin, ST2, and REG3a biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD Blood Adv. 2024 06 25; 8(12):3284-3292. . View in PubMed
  • A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHDTransplant Cell Ther. 2024 Jun; 30(6):603. e1-603. e11. . View in PubMed
  • Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy Transplant Cell Ther. 2024 May; 30(5):475-487. . View in PubMed
  • Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis Blood Adv. 2024 04 23; 8(8):2047-2057. . View in PubMed
  • Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment Nat Commun. 2024 Apr 18; 15(1):3258. . View in PubMed
  • A Day 14 Endpoint for Acute GVHD Clinical Trials Transplant Cell Ther. 2024 Apr; 30(4):421-432. . View in PubMed
  • A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA Blood. 2024 03 21; 143(12):1112-1123. . View in PubMed
  • The utility of biomarkers in acute GVHD prognostication Blood Adv. 2023 09 12; 7(17):5152-5155. . View in PubMed
  • Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD Blood Adv. 2023 08 22; 7(16):4479-4491. . View in PubMed
  • Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19 JAMA Oncol. 2023 08 01; 9(8):1108-1112. . View in PubMed
  • Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia PatientsTransplant Cell Ther. 2023 06; 29(6):356. e1-356. e7. . View in PubMed
  • Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival Blood Adv. 2023 05 09; 7(9):1823-1830. . View in PubMed
  • SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report J Immunother Cancer. 2023 01; 11(1). . View in PubMed
  • COVID-19 outcomes in children, adolescents and young adults with cancer Int J Cancer. 2022 Dec 01; 151(11):1913-1924. . View in PubMed
  • Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseTransplant Cell Ther. 2021 12; 27(12):988. e1-988. e7. . View in PubMed
  • Ultra-High Dose Vitamin D in Pediatric Hematopoietic Stem Cell Transplantation: A Nonrandomized Controlled TrialTransplant Cell Ther. 2021 12; 27(12):1001. e1-1001. e9. . View in PubMed
  • Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series EBioMedicine. 2021 May; 67:103355. . View in PubMed
  • Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity medRxiv. 2021 Mar 02. . View in PubMed
  • Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients Biol Blood Marrow Transplant. 2020 05; 26(5):911-919. . View in PubMed
  • Association between Vitamin D and Risk for Early and Late Post-Transplant Complications Biol Blood Marrow Transplant. 2020 02; 26(2):343-350. . View in PubMed
  • Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients Am J Transplant. 2018 09; 18(9):2238-2249. . View in PubMed
  • Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy J Infect Dis. 2017 09 15; 216(6):678-687. . View in PubMed
  • Characterizing the Cellular Immune Response to Parainfluenza Virus 3 J Infect Dis. 2017 07 15; 216(2):153-161. . View in PubMed
  • Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease Bol Med Hosp Infant Mex. 2016 Jan – Feb; 73(1):31-40. . View in PubMed

Similar People